Table 2.
Demographics and clinical characteristics of patients.
Source | CCF/PCGP/SJLIFE | ||||
---|---|---|---|---|---|
Age group | Children | Adolescent | Young adult | Unknown | Total |
Female/Male | 600/582 | 67/97 | 5/15 | 14/13a | 686/707 |
Mean age of onset | 6.1 ± 4.5 | 16.9 ± 1.3 | 22 ± 2.4 | NA | 7.6 ± 5.8 |
All solid tumors (1507) | 1182 | 164 | 20 | 141 | 1507 |
Central nervous system (323) | 266 | 23 | 2 | 32 | 323 |
Wilms tumor (207) | 189 | 2 | 1 | 15 | 207 |
Neuroblastoma (190) | 158 | 2 | 1 | 29 | 190 |
Rhabdomyosarcoma (134) | 114 | 14 | 1 | 5 | 134 |
Osteosarcoma (129) | 78 | 42 | 5 | 4 | 129 |
Retinoblastoma (98) | 84 | 14 | 98 | ||
Ewing’s sarcoma (95) | 58 | 27 | 5 | 5 | 95 |
Soft tissue sarcoma (93) | 69 | 17 | 3 | 4 | 93 |
High-grade glioma (80) | 63 | 8 | 9 | 80 | |
Germ cell tumor (74) | 57 | 11 | 1 | 5 | 74 |
Low-grade glioma (24) | 8 | 1 | 15 | 24 | |
Adrenocortical carcinoma (22) | 20 | 1 | 1 | 22 | |
Carcinoma (14) | 7 | 7 | 14 | ||
Giant cell tumor (3) | 0 | 3 | 3 | ||
Renal cell carcinoma (3) | 2 | 1 | 3 | ||
Low malignant potential renal tumors (2) | 2 | 2 | |||
Basal cell carcinoma (1) | 1 | 1 | |||
Paraganglioma (1) | 1 | 1 | |||
Other solid tumor (10) | 3 | 4 | 3 | 10 | |
Non-malignant tumor (4) | 3 | 1 | 4 |
CCF Cleveland Clinic Foundation, PCGP Pediatric Cancer Genome Project, SJLIFE, St. Jude Life Cohort. aGender data were not available for all the patients in this group.